期刊文献+

肝细胞生长因子、血管紧张素Ⅱ水平与动态血压的关系 被引量:1

Study of the relationship between 24-hour ambulatory blood pressure and hepatocyte growth factor, angiotensin Ⅱ
下载PDF
导出
摘要 目的探讨肝细胞生长因子(HGF:hepatocyte growth factor)、血管紧张素Ⅱ(AngⅡ:angiotensinⅡ)与高血压及血压昼夜节律性的关系。方法选择41例高血压病患者及19例正常血压者行24小时动态血压测定,分析HGF、AngⅡ与高血压及血压昼夜节律性的关系。比较不同高血压级别HGF、AngⅡ浓度;杓型及非杓型高血压患者HGF、AngⅡ浓度;HGF、AngⅡ与动态血压各指标的关系。分析HGF与AngⅡ之间的关系。结果EH组血浆AngⅡ、HGF较对照组明显升高,且随病程严重程度平行,差异有统计学意义。EH组中非杓型亚组血浆HGF、AngⅡ较杓型组高。非杓型高血压亚组中HGF与24hDBP、dDBP、nSBP、nDBP正相关,相关系数分别为0.553、0.592、0.627、0.487,P值分别为0.021、0.012、0.007、0.047;非杓型高血压亚组中AngⅡ与24hSBP、dSBP、nDBP正相关,相关系数分别为0.584、0.601、0.523;P值分别为0.014、0.011、0,030。HGF及AngⅡ与杓型高血压各参数无显著相关性。高血压组与对照组比较,血浆AngⅡ、HGF相关系数分别为0.562,0.143,P值分别为P<0.01,P=0.561。结论AngⅡ的升高是决定高血压的发生发展及高血压患者昼夜节律性的重要因素之一。HGF浓度高低可以反映昼夜节律消失导致内皮受损严重程度。高血压患者HGF的升高可能是一种代偿性保护反应。HGF可能可以作为ACEI或ARB类药物干预治疗疗效的一个重要指标。 Objective To study the relationship between ambulatory blood pressure and hepatocyte growth factor, angiotensin Ⅱ. Methods We investigated the relationship by measuring the serum HGF and AngⅡ concentration and performing 24-h ambulatory blood pressure monitoring in 60 randomly selected subjects. Results The serum HGF and AngⅡ levels in patients with EH were higher than those in control. The changes Of HGF and AngⅡ levels were related to the severity of disease. The Serum HGF and AngⅡ levels in the non-dipper sub-group were higher than those in The dipper sub-group. HGF concentration was positively correlated with 24hDBP、dDBP, nSBP and nDBP (r=0.553, P=0.021; r=0.592, P=0.012; r=0.627, P=0.007; r =0.487, P=0.047, respectively). AngⅡ concentration was positively correlated with 24hSBP, dSBP and nDBP (r=0.584, P=0.014; r=0.601, P=0.011; r=0.523, P=0.030, respectively). HGF concentration was positively correlated with AngⅡ concentration in EH group (r=0.562, P〈0.01). Conclusions Ang Ⅱ may be the important cause of the hypertension and has effect on circadian rhythm of blood pressure in EH. The results also indicated that there is a relationship between blood pressure measured by ABPM and serum HGF or Ang Ⅱ concentration, HGF might be evaluated as a possible biochemical index of damage of endothelial cells due to hypertension.
出处 《海南医学》 CAS 2008年第4期9-11,共3页 Hainan Medical Journal
关键词 高血压 肝细胞生长因子 血管紧张素Ⅱ 动态血压 hypertension hepatocyte growth factor angiotensin Ⅱ ambulatory blood pressure
  • 相关文献

参考文献9

  • 1Nishimura M, Ushiyama M, Maruyama Y, et al.Association of human hepatocyte growth Factor with Hem dialysis hypotension. Hypertens Res,2000,23: 581-586.
  • 2Lemmer B, Witte K, Madabe T, et al.Effects of enalaprilat on circadian profiles in blood pressure and heart rote of spontaneously and transgenic hyperhensive rats.J Cardiovase Phamacol,1994,23: 311-314.
  • 3Schnecko A, Witte K, Lemmer B. Effects of the angiotensin Ⅱ receptor antagonist Losartan on 24- hour blood pressur profiles of primary and secondary hypertensive Rals. J Cardiovase Pharmacol, 1995,26(2):214-221.
  • 4Nakamura S, Morishita R, Ogihara T, et al. Hepatocyte growth factor as a potential Indext of complication in diabetes mellitus.J Hypertension,1998,16: 2019-2026.
  • 5Hoshide S, Kario K, Hoshide Y, et al. Associations between nondipping of nocturnal Blood pressure decease and cardiovascular target organ damage in strictly selected community dwelling normotensive[J]. Am J Hypertens,2003,16:434--438.
  • 6Miller RC, Pelton JT, Huggins JP. Endothelins: Form receptor to medicine. Trends Pharmacol Sci, 1993,14:54-601.
  • 7Evans PR, Davis WR, Wallace JM, et al. Humoral factors determing the blood pressure response to conberting enzyme inhibition and calcium channel blocdade. Am J Hypertens,1990,3:605-611.
  • 8Morishita R, Moriguchi A, Higaki J, et al. Hepatocyte growth factor (HGF) as a Potential index of severity of hypertention[J]. Hypertens Res,1999,22(3):161-167.
  • 9Nishimurs M, Ushiyama M, Ohtsuka K, et al. Serum hepatocyte growth factor as A possible indicator of vascular lesions [J]. J Clin Endocrinol Metab, 1999,84(7):2475 -2480.

同被引文献21

  • 1Manchang Liu, Hiroshi Takahashi, Yoshiki Morita, et al. Non - dip- ping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant ,2003,18 (3) : 563 - 569.
  • 2Narita I, Okada M, Naqai M, et al. The circadian blood pressure rhythm in non -diabetic hemodialysis patients. Hypertens Res,2001, 24(2) :111 - 117.
  • 3Fukuda M, Munemura, Usami T, et al. Nocturnal blood pressure is elevated with natriuresis and proteinuria as renal function deteriorates in nephropathy,2004,65 ( 2 ) :621 - 625.
  • 4Fukuda M, Mizuno M, Yamanaka T, et al. Patients with renal dysfunction require a longer duration until blood pressure dips during the night. Hypertension ,2008,52 ( 6 ) : 1155 - 1160.
  • 5Grassi G, Seravalle G, Arenare F, et al. Behaviour of regional adrenergic outflow in mild - to - moderate renal failure. J Hypertens, 2009,27 ( 3 ) :562 - 566.
  • 6Jensen L, Pedersen E. Nocturnal Blood Pressure and Relation to Vaso- active Hormones and Renal Function in Hypertension and Chronic Renal Failure. Blood pressure, 1997,6 ( 6 ) : 332 - 342.
  • 7Karasek M, Szuflet A, Zylinska K, et al. Circadian serum melatonin profiles in patients suffering from chronic renal failure. Neuro Endocrinol Lett,2002,23 ( 1 ) :97 - 102.
  • 8Karasek M, Szuflet A, Chrzanowski W, et al. Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuro Endocrinol Lett,2005,26 (6) :653 - 656.
  • 9Scheer FA, Van Montfrans GA, van Someren E J, et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension,2004, 43 (2) : 192 - 197.
  • 10De Santo RM, Bartiromo M, Cesare MC, et al. Sleeping disorders in patients with end - stage renal disease and chronic kidney disease. J Ren Nutr,2006,16 (3) :224 - 228.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部